Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress
about
The role of oxidized cytochrome c in regulating mitochondrial reactive oxygen species production and its perturbation in ischaemia4'-Chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats.Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioningLeptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore.Urotensin-ⅡReceptor Antagonist SB-710411 Protects Rat Heart against Ischemia-Reperfusion Injury via RhoA/ROCK Pathway.Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular systemComparative effects of urocortins and stresscopin on cardiac myocyte contractilityInhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.Cardioprotective growth factors.Targeting urocortin signaling pathways to enhance cardioprotection: is it time to move from bench to bedside?Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection.Urocortin protects chondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis?The role of succinate and ROS in reperfusion injury - A critical appraisal.Inhibition of NAADP signalling on reperfusion protects the heart by preventing lethal calcium oscillations via two-pore channel 1 and opening of the mitochondrial permeability transition pore.Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease.New targets of urocortin-mediated cardioprotection.Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia-Reperfusion Injury.Mechanisms underlying the activation of L-type calcium channels by urocortin in rat ventricular myocytes.
P2860
Q28568843-64330D58-20A6-4130-AF68-94ED91D00420Q34111148-0BC9D23F-0487-4E5E-8A1E-8F41C96D20E1Q34187821-F74CBC79-AF1A-4F34-ABEE-E754BCE39217Q34212278-F9BB9931-CDCE-46D4-AFC6-89AD75C7AAE9Q35895186-4B00BB90-BD54-44E8-8CD6-13CFA5884214Q35996841-4C5AAC97-7E6F-41D6-BD84-E89702FAD5F3Q36021840-A7C85295-AB42-4B9E-8C3D-2BCC4A51FFE5Q37069429-0FFF51BC-F636-4933-8CA8-152C60E674D5Q37100186-6D8A7E53-7E06-4659-B6F6-E989B28F7858Q37218470-FC2E9CD9-A414-4619-8F51-D489A6D1A672Q37393585-BF23A630-8849-41DB-AE71-EC6D4095F23AQ38119156-42936B62-73DC-4014-956F-C4BB78ADD1E6Q38954134-77FCAD2E-152F-4E18-82B3-816FF458D740Q39127184-F26C0B90-4F87-4B2B-97E8-7514B58AF9C0Q39423100-D23B2F27-AD6C-464E-8306-99116332710AQ41880567-E645F4FD-C50C-443F-A558-06869E0AFC81Q42038020-0AA36E71-2304-4C6A-AAA3-5BF46AFCD2B3Q42709174-7572E80F-0DFF-473C-B211-9926B3656647Q50932525-D6480F31-269D-45A9-843E-E7C14EA744ECQ54689954-01F1E10D-6494-4514-A70A-12A00E2567B3
P2860
Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Urocortin prevents mitochondri ...... y by reducing oxidative stress
@ast
Urocortin prevents mitochondri ...... y by reducing oxidative stress
@en
type
label
Urocortin prevents mitochondri ...... y by reducing oxidative stress
@ast
Urocortin prevents mitochondri ...... y by reducing oxidative stress
@en
prefLabel
Urocortin prevents mitochondri ...... y by reducing oxidative stress
@ast
Urocortin prevents mitochondri ...... y by reducing oxidative stress
@en
P2093
P2860
P50
P1476
Urocortin prevents mitochondri ...... y by reducing oxidative stress
@en
P2093
Anastasis Stephanou
David S Latchman
Paul A Townsend
Richard A Knight
Samantha J Clarke
Tiziano M Scarabelli
P2860
P304
P356
10.1152/AJPHEART.01135.2006
P577
2007-05-04T00:00:00Z